Charles River Laboratories International Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Charles River Laboratories International Inc.
Former names
Charles River Laboratories Holdings Inc
Ownership
Public
Status
Active
SIC code
8731 — Services-Commercial Physical & Biological Research
Headquarters city
Wilmington
Headquarters state / province
Massachusetts
Headquarters country
United States
Fiscal year end
December
Ticker symbol
CRL
Primary stock exchange
NYSE

Identifiers

SEC CIK
0001100682
EIN
06-1397316

Board of directors

Follow this board

Chief executives

James C. Foster · Chairman, President and CEO
Dates unknown
Birgit Girshick · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of May 5, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

9 of this board's directors also sit on 12 other boards.

Network of Charles River Laboratories International Inc.'s board connections BioMarin Pharmaceutical Inc. BioMarin Pharmaceutica... CECO Environmental Corp. CECO Environmental Cor... Cardinal Health Inc. Cardinal Health Inc. Carrier Global Corporation Carrier Global Corpora... Elanco Animal Health Incorporated Elanco Animal Health I... Kailera Therapeutics Inc. Kailera Therapeutics I... Maze Therapeutics Inc. Maze Therapeutics Inc. Pacira BioSciences Inc. Pacira BioSciences Inc... Rallybio Corporation Rallybio Corporation Rapport Therapeutics Inc. Rapport Therapeutics I... Regeneron Pharmaceuticals Inc. Regeneron Pharmaceutic... Roper Technologies Inc. Roper Technologies Inc... Abraham Ceesay Abraham Ceesay Craig B. Thompson Craig B. Thompson Deborah Turner Kochevar Deborah Turner Koche... Mark J. Enyedy Mark J. Enyedy Martin Mackay Martin Mackay Nancy C. Andrews Nancy C. Andrews Richard F. Wallman Richard F. Wallman Steven Barg Steven Barg Virginia M. Wilson Virginia M. Wilson Charles River Laboratories...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$4,364
1 purchase by 1 insider
Sold, last 12 months
$42,606,413
18 sales by 6 insiders
Date Insider Transaction Shares Price Value
Aug 25, 2026 James C. Foster Director Option exercise +21,132 $194.12 $4,102,144
Aug 25, 2026 James C. Foster Director Option exercise +12,429 $208.44 $2,590,701
Aug 25, 2026 James C. Foster Director Open-market sale −33,561 $300.00 $10,068,300
Aug 19, 2026 Parisotto Shannon M Officer (CEVP, Disc & Safety Assessment) Option exercise +2,039 $194.12 $395,811
Aug 19, 2026 Birgit Girshick Director, Officer (Chief Executive Officer) Gift −528 — —
Aug 19, 2026 Parisotto Shannon M Officer (CEVP, Disc & Safety Assessment) Open-market sale −2,039 $294.12 $599,711
Aug 18, 2026 Nancy C. Andrews Director Option exercise +573 $164.30 $94,144
Aug 18, 2026 Nancy C. Andrews Director Open-market sale −573 $285.24 $163,443
Aug 11, 2026 Parisotto Shannon M Officer (CEVP, Disc & Safety Assessment) Option exercise +3,714 $179.66 $667,257
Aug 11, 2026 Birgit Girshick Director, Officer (Chief Executive Officer) Option exercise +6,500 $179.66 $1,167,790
Aug 11, 2026 Parisotto Shannon M Officer (CEVP, Disc & Safety Assessment) Open-market sale −3,714 $279.66 $1,038,657
Aug 11, 2026 Birgit Girshick Director, Officer (Chief Executive Officer) Open-market sale −6,500 $279.90 $1,819,350
Aug 10, 2026 James C. Foster Director Option exercise +28,733 $179.66 $5,162,171
Aug 10, 2026 LaPlume Joseph W Officer (EVP, Corp Strategy & Develop) Gift −257 — —
Aug 10, 2026 James C. Foster Director Open-market sale −28,733 $275.00 $7,901,575

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.